Contact this trialFirst, we need to learn more about you.
BCL-2 Inhibitor
PF-06821497 for Small Cell Lung Cancer
Recruiting1 awardPhase 1
Dallas, Texas
This trial is testing a new drug to treat adult patients with small cell lung cancer, castration resistant prostate cancer, or follicular lymphoma who have relapsed or are refractory to standard therapies.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.